Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT, United States of America.
PLoS One. 2022 Oct 20;17(10):e0276548. doi: 10.1371/journal.pone.0276548. eCollection 2022.
Venous thromboembolism (VTE) is an uncommon, but potentially morbid, complication following foot and ankle fractures. Current standard is to not administer thromboprophylaxis to patients with such injuries. Nonetheless, patient and fracture factors might affect this risk/benefit consideration. The goal of this study was to determine what patients are most at risk.
The M53Ortho Pearldiver database was used to identify patients with fractures isolated to the foot and ankle that were treated non-operatively or operatively. Patients with pilon, other appendicular fractures remote from the foot and ankle, and other traumatic injuries were excluded. The 90-day occurrence of VTE was identified based on codes for deep vein thrombosis or pulmonary embolism. Characteristics of those patients who did and did not have VTEs were compared using chi-square analyses. Multivariate logistical regression was then performed to determined factors independently associated with VTE. Finally, timing of VTE relative to fracture was analyzed.
A total of 298,886 patients with isolated foot or ankle fractures were identified, of which 1,661 (0.56%) had VTE in the 90 days following fracture. In terms of timing, 27.3% occurred in the first week, and 49.8% occurred in the first three weeks. Independent risk factors for VTE included (in decreasing order):prior VTE (odd ratio [OR] = 25.44), factor V Leiden (OR = 24.34), active cancer (OR = 1.84), specific fracture relative to metatarsal fracture (multiple fractures [OR: 1.51], ankle fracture [OR = 1.51], and calcaneus fracture [OR = 1.24]), surgical treatment (OR = 1.41), male sex (OR = 1.19), greater Elixhauser index (OR = 1.05), and increasing age (OR:1.05 per decade) (p<0.05 for each).
The present study found that, although only 0.56% of isolated foot and ankle fractures had a VTE within ninety days. Defined risk factors, such as Factor V Leiden, prior VTE, surgical treatment, active cancer, specific fracture patterns, and surgical treatment significantly affected the odds of their occurrence.
静脉血栓栓塞症(VTE)是足部和踝关节骨折后一种罕见但可能危及生命的并发症。目前的标准是不对这类损伤的患者进行血栓预防。然而,患者和骨折因素可能会影响这种风险/获益的考虑。本研究的目的是确定哪些患者风险最大。
使用 M53OrthoPearldiver 数据库确定了接受非手术或手术治疗的足部和踝关节单纯骨折患者。排除了胫骨骨折、远离足部和踝关节的其他四肢骨折和其他创伤性损伤的患者。根据深静脉血栓或肺栓塞的代码确定 90 天内 VTE 的发生情况。使用卡方分析比较发生和未发生 VTE 的患者的特征。然后进行多变量逻辑回归以确定与 VTE 独立相关的因素。最后,分析 VTE 与骨折的时间关系。
共确定了 298886 例足部或踝关节单纯骨折患者,其中 1661 例(0.56%)在骨折后 90 天内发生 VTE。就时间而言,27.3%发生在第一周,49.8%发生在前三周。VTE 的独立危险因素按降序排列依次为:既往 VTE(比值比[OR] = 25.44)、因子 V 莱登(OR = 24.34)、活动性癌症(OR = 1.84)、特定骨折相对于跖骨骨折(多发骨折[OR:1.51]、踝关节骨折[OR = 1.51]和跟骨骨折[OR = 1.24])、手术治疗(OR = 1.41)、男性(OR = 1.19)、Elixhauser 指数更高(OR = 1.05)和年龄增加(OR:每十年增加 1.05)(p<0.05)。
本研究发现,尽管只有 0.56%的足部和踝关节单纯骨折在 90 天内发生 VTE,但定义明确的危险因素,如因子 V 莱登、既往 VTE、手术治疗、活动性癌症、特定骨折模式和手术治疗,显著影响了其发生的几率。